BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 21681274)

  • 1. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
    Koopai M; Mortazavi H; Khatami A; Khodashenas Z
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris.
    Avgerinou G; Papafragkaki DK; Nasiopoulou A; Markantoni V; Arapaki A; Servitzoglou M; Katsambas A; Stavropoulos PG
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):430-5. PubMed ID: 22221266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
    Russo I; Saponeri A; Michelotto A; Alaibac M
    In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
    Barnadas MA; Rubiales MV; Gich I; GelpĂ­ C
    Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
    Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
    J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
    Sharma VK; Prasad HR; Khandpur S; Kumar A
    Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
    De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
    Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
    Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High anti–desmoglein 3 antibody ELISA index and negative indirect immunofluorescence result in a patient with pemphigus vulgaris in remission: evaluation of the antibody profile by newly developed methods.
    Nakahara T; Takagi A; Yamagami J; Kamiya K; Aoyama Y; Iwatsuki K; Ikeda S
    JAMA Dermatol; 2014 Dec; 150(12):1327-30. PubMed ID: 25075929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
    Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
    Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.